3 Stocks to Avoid in Biotech


Public outrage over escalating drug prices made the biotechnology industry generally toxic to plenty of portfolios to begin the year, and fear of political backlash isn't helping. The iShares Nasdaq Biotechnology index , whichtracks over 180 biotech stocks listed on the exchange, is still down about 22% for the year, while the broader S&P 500 benchmark has notched a near-5% gain.



from Biotech News